Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

about

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

Item

http://www.wikidata.org/entity/Q47552430

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@en

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@nl

type

Item

label

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@en

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@nl

prefLabel

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@en

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.

@nl

P1476

Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study

@en

P2093

C Eller-Vainicher

http://www.w3.org/2001/XMLSchema#string

E Cairoli

http://www.w3.org/2001/XMLSchema#string

G Goggi

http://www.w3.org/2001/XMLSchema#string

L Roggero

http://www.w3.org/2001/XMLSchema#string

M Arosio

http://www.w3.org/2001/XMLSchema#string

S Palmieri

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonates for the prevention and treatment of osteoporosis

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

How should we define light or intermittent smoking? Does it matter?

Bone turnover markers: use in osteoporosis.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates.

Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.

Treatment needs and current options for postmenopausal osteoporosis.

P2888

s40618-018-0829-9

P304

1005-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40618-018-0829-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Iacopo Chiodini

P577

2018-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29340971

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis